Current Enzyme Inhibition
Title: Editorial [Hot topic: TGF-β Signaling and its Inhibition: Implication in Fibrosis (Guest Editor: Asish K. Ghosh)]
Volume: 6 Issue: 2
Author(s): Asish K. Ghosh
Affiliation:
Export Options
About this article
Cite this article as:
K. Ghosh Asish, Editorial [Hot topic: TGF-β Signaling and its Inhibition: Implication in Fibrosis (Guest Editor: Asish K. Ghosh)], Current Enzyme Inhibition 2010; 6 (2) . https://dx.doi.org/10.2174/157340810791233015
DOI https://dx.doi.org/10.2174/157340810791233015 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
12
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Muscle Metabolism and Exercise Capacity in Cachexia
Current Pharmaceutical Design Anti-Inflammatory Iridoids of Botanical Origin
Current Medicinal Chemistry Postoperative Atrial Fibrillation - What Do We Really Know?
Current Vascular Pharmacology SemanticDB: A Semantic Web Infrastructure for Clinical Research and Quality Reporting
Current Bioinformatics Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
Recent Patents on Cardiovascular Drug Discovery A Conceptual Framework of Comorbidity for Investigation in the Context of Psychiatric Disturbance
Current Psychiatry Reviews Pathophysiological Basis for Anticoagulant and Antithrombotic Therapy in Pulmonary Hypertension
Cardiovascular & Hematological Agents in Medicinal Chemistry CTLA-4Ig: Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery Editorial [Hot Topic: Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design Biologic Therapy and Treatment Options in Diabetic Retinopathy with Diabetic Macular Edema
Current Drug Safety Ventricular Extrasystoles after First Dose of Sofosbuvir in a Patient Treated with Propranolol but not with Amiodarone: A Case Report
Reviews on Recent Clinical Trials Human Heart Failure: A Proteomics Perspective
Current Proteomics An Agathokakological Tale of Δ<sup>9</sup>-THC: Exploration of Possible Biological Targets
Current Drug Targets Interactions of the Aryl Hydrocarbon Receptor with Inflammatory Mediators:Beyond CYP1A Regulation
Current Drug Metabolism PPARγ-targeting Potential for Radioprotection
Current Drug Targets Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical Based Evidence
Current Pharmaceutical Design The Impact of Substance P on the Pathogenesis of Insulin Resistance Leading to Gestational Diabetes
Current Pharmaceutical Biotechnology Unmet Needs in Schizophrenia
CNS & Neurological Disorders - Drug Targets Measuring the Burden of Disease in the United Arab Emirates, 1990 – 2019: A Road to Future
New Emirates Medical Journal Chemotherapeutic Options for Colorectal Cancer Patients with Cardiovascular Diseases.
Reviews on Recent Clinical Trials